Researchers reported efficacy and safety data through 48 months of continuous pegcetacoplan treatment across OAKS, DERBY and ...

Investigators crafted a classification for age-related macular degeneration (AMD) based on optical coherence tomography (OCT) ...

Investigators reviewed the application of micropulse laser therapy in addition to aflibercept injections in patients with ...

Investigators reviewed a large electronic health records database to evaluate the association between varicose veins and CSCR ...

Investigators evaluated the clinical benefit of a sustained‐release dexamethasone intravitreal implant as a second‐line ...

Brensocatib, a small molecule, oral, reversible inhibitor of dipeptidyl peptidase 1 (DPP1), received Priority Review from the FDA for the treatment of patients with non-cystic fibrosis bronchiectasis.

Identifying the correct uveitis type can help reveal underlying systemic infections, neoplastic conditions, and other ...

Researchers tested more than 65,000 patients with more than 30 solid tumor types and found the rate of HER2 positivity was about 3%.

After months with an appointed caretaker, the US Centers for Disease Control and Prevention (CDC) finally has an official director.

Filtration surgery effectively lowers IOP and slows central visual field deterioration in open-angle glaucoma and high myopia.

Two inflammatory tear fluid biomarkers may serve a diagnostic purpose in thyroid eye disease, according to a cross-sectional study.

Faricimab, compared with aflibercept, reduces the risk of epiretinal membrane formation in eyes with diabetic macular edema, research shows.